|Home | About | Journals | Submit | Contact Us | Français|
BH3 mimetics are small-molecule inhibitors of B-cell lymphoma-2 (Bcl-2) and Bcl-xL, which disrupt the heterodimerisation of anti- and pro-apoptotic Bcl-2 family members sensitising cells to apoptotic death. These compounds have been developed as anti-cancer agents to counteract increased levels of Bcl-2 proteins often present in cancer cells. Application of a chemotherapeutic drug supported with a BH3 mimetic has the potential to overcome drug resistance in cancers overexpressing anti-apoptotic Bcl-2 proteins and thus increase the success rate of the treatment. We have previously shown that the BH3 mimetics, BH3I-2′ and HA14-1, induce Ca2+ release from intracellular stores followed by a sustained elevation of the cytosolic Ca2+ concentration. Here we demonstrate that loss of Bax, but not Bcl-2 or Bak, inhibits this sustained Ca2+ elevation. What is more, in the absence of Bax, thapsigargin-elicited responses were decreased; and in two-photon-permeabilised bax−/− cells, Ca2+ loss from the ER was reduced compared to WT cells. The Ca2+-like peptides, CALP-1 and CALP-3, which activate EF hand motifs of Ca2+-binding proteins, significantly reduced excessive Ca2+ signals and necrosis caused by two BH3 mimetics: BH3I-2′ and gossypol. In the presence of CALP-1, cell death was shifted from necrotic towards apoptotic, whereas CALP-3 increased the proportion of live cells. Importantly, neither of the CALPs markedly affected physiological Ca2+ signals elicited by ACh, or cholecystokinin. In conclusion, the reduction in passive ER Ca2+ leak in bax−/− cells as well as the fact that BH3 mimetics trigger substantial Ca2+ signals by liberating Bax, indicate that Bax may regulate Ca2+ leak channels in the ER. This study also demonstrates proof-of-principle that pre-activation of EF hand Ca2+-binding sites by CALPs can be used to ameliorate excessive Ca2+ signals caused by BH3 mimetics and shift necrotic death towards apoptosis.
Disrupted regulation of apoptosis is the hallmark of carcinogenesis allowing accumulation of further genetic mutations and acquisition of metastatic properties.1 Cancer cells often express increased levels of anti-apoptotic Bcl-2 (B-cell lymphoma-2) proteins, which provides additional protection against cell death signals2, 3 correlating with chemotherapy resistance and poor prognosis for patients.4
As anti-cancer therapies often target the mitochondrial apoptotic pathway regulated by the Bcl-2 family, overexpression of anti-apoptotic proteins in cancer presents one of the leading challenges to overcome for effective treatment.5 Mechanism of apoptosis induction in cancer is predominantly altered upstream of Bax and Bak.6 Therefore pharmacological suppression of anti-apoptotic Bcl-2 members leading to activation of Bax and Bak should, in principle, be capable of recovering the programmed cell death.7, 8
BH3 mimetics are small-molecule synthetic inhibitors of Bcl-2 and Bcl-xL, specifically developed as anti-cancer agents.7 They mimic activated BH3-only proteins by disrupting the heterodimerisation of anti- and pro-apoptotic Bcl-2 family members, and thus sensitising cells to apoptosis. HA14-1 was the first BH3 mimetic obtained by molecular modelling that had the ability to displace Bax from Bcl-2, followed by the induction of cell death.7 Later, a family of seven members of BH3 mimetics, called BH3 inhibitors (BH3Is), was developed and shown to displace Bak peptide from Bcl-xL, trigger apoptosis, cytochrome c release and caspase activation.9 A natural BH3 mimetic gossypol, isolated from the cotton plant (Gossypium), is also capable of inhibiting Bcl-2, Bcl-xL and Mcl-1.10, 11
Simultaneous application of a chemotherapeutic agent and a BH3 mimetic can potentially overcome drug resistance in cancers overexpressing anti-apoptotic Bcl-2 proteins and thus increase the treatment success rate. BH3I-2′ and HA14-1 were shown to sensitise leukaemic cells in vitro to TRAIL-induced apoptosis.12 Gossypol (AT-101) was found to increase radiation efficacy in head and neck cancer cell lines in vitro;13 and recently underwent phase II clinical trials in combination with docetaxel14 and with androgen deprivation therapy.15 A particularly interesting approach is to develop chemically tailored BH3 mimetics that interact specifically with the anti-apoptotic proteins overexpressed in a target cancer type.8
As exciting as the prospect of Bcl-2 inhibition might seem, accumulating evidence shows that BH3 mimetics often affect intracellular Ca2+ homoeostasis. Previously we have reported that HA14-1 and BH3I-2′ deplete the ER Ca2+ store causing a sustained elevated cytosolic Ca2+ concentration in pancreatic acinar cells (PACs).16 Others have demonstrated that HA14-1 causes Ca2+ deregulation in platelets, HeLa and HEK-293T cells.17 This immediately triggers questions about safe and specific use of BH3 mimetics, especially given the crucial role of Ca2+ in the regulation of a wide variety of intracellular process including muscle contraction,18 enzyme secretion,19 fertilisation,20, 21 cell proliferation22 and death.23 This is particularly important in the pancreas, as physiological Ca2+ oscillations control enzyme secretion in PACs, whereas abnormal Ca2+ signals are the hallmark of the initial stages of a severe necrotising disease of the pancreas – acute pancreatitis.24, 25, 26 This study aims to assess the effects of BH3 mimetics on Ca2+ handling in relation to activation of pro-apoptotic Bax in PACs. Also, we draw conclusions about the involvement of Bax in intracellular Ca2+ signalling and propose means to reduce the excessive Ca2+ signals enabling modulation of the cell death mechanisms.
BH3I-2′ and HA14-1 were shown to induce a slow Ca2+ release from the intracellular stores.16 Pharmacological inhibition of inositol 1,4,5-triphosphate receptors (IP3Rs) and ryanodine receptors (RyRs) led to a decreased Ca2+ release from the ER of permeabilised PACs but did not completely block it. This indicates that IP3Rs and RyRs were not the primary source of BH3 mimetic-elicited Ca2+ release but merely amplified it.16 Here PACs, isolated from wild-type (WT) mice as well as animals with a loss-of-function mutation in one of the following genes: bcl-2, bak or bax were treated with 5μM BH3I-2′ (Figure 1a) or 30μM HA14-1 (Figure 1b) in the absence of extracellular Ca2+. In WT, bcl-2−/− and bak−/− cells, these BH3 mimetics caused sustained elevations of the cytosolic Ca2+ concentration ([Ca2+]i), whereas in bax−/− cells the Ca2+ signal generation was largely abolished (Figures 1a and b). Quantitative comparison of the responses to BH3I-2′ (Figure 1c) and HA14-1 (Figure 1d) confirmed that loss of Bax, but not Bcl-2 or Bak, dramatically inhibited the BH3 mimetic-induced elevation of the [Ca2+]i (P<0.001). The responses to BH3I-2′ or HA14-1 in bax−/− cells, if present at all, were mainly short-lasting Ca2+ transients, whereas sustained elevation was mostly inhibited (Figures 1e and f). Further, measurements of Ca2+ release from the ER in two-photon-permeabilised PACs revealed that BH3I-2′ not only appears to release less Ca2+ from the ER of bax−/− compared to WT cells (P<0.01; Figures 2a and b) but also that the apparent rate of release was slower than in WT cells. Consequently, τ1/2 for bax−/− (226.5±25.9s) cells was higher than for WT cells (145.1±19.3s; P<0.05; Figure 2c), which translates into longer time needed for the fluorescence of the Ca2+ indicator to decrease by half the difference between baseline and final values. Images of a PAC doublet before and after laser permeabilisation are depicted in Figure 2d. Increasing the ER store loading with CDN1163, a postulated allosteric activator of SERCA2b (sarco/endoplasmic reticulum Ca2+-ATPase, isoform 2b),27 did not significantly affect the responses to BH3I-2′ in bax−/− cells (Figure 2e). Finally, BH3I-2′ increased apoptosis in WT cells by ~20.6±3.8% and necrosis by 26.1±2.7% over control levels; these effects were completely abolished by intracellular Ca2+ chelation with BAPTA (P<0.05; Figure 2f; bars and corresponding images). In bax−/− cells, BH3I-2′ did not affect apoptosis and only slightly increased necrosis (by 8.8±3.8%); the latter was completely inhibited by BAPTA (P<0.05; Figure 2f). The effects of BH3I-2′ on cell death were substantially less pronounced in bax−/− cells compared to WT cells (P<0.05 for both apoptosis and necrosis; Figure 2f).
The effects of Bax on intracellular Ca2+ homoeostasis were investigated in PACs that had their ER stores depleted with the SERCA blocker thapsigargin under simultaneous inhibition of IP3Rs (by 20mM caffeine) and RyRs (by 10μM ruthenium red).16, 28 Average traces (Figure 3a) and average areas of responses (Figure 3a, inset) demonstrate that [Ca2+]i elevation caused by the ER depletion was significantly smaller in bax−/− cells than in WT cells (P<0.001). Inhibition of Ca2+ extrusion by 1mM La3+ preserved the difference in size of the thapsigargin-induced Ca2+ release between WT and bax−/− cells (P<0.01; Figure 3b) indicating that this difference was not due to enhanced cytosolic Ca2+ extrusion in bax−/− cells. Further, in two-photon-permeabilised PACs, thapsigargin also released less Ca2+ from the ER of bax−/− than from WT cells (P<0.05; Figures 3c and d) and the apparent rate of release was slower in bax−/− compared to WT cells (τ1/2=278.3±34.2s versus 166.6±27.7s; P<0.05; Figure 3e). Emptying the ER store with a supramaximal dose of acetylcholine (ACh, 10μM) resulted in only very slightly diminished responses in bax−/− cells in the first 100s (62.7±3.7 a.u.) compared to WT cells (79.2±4.4 a.u.; P<0.01; Figures 3f and g). The second emptying of the ER store, preceded by partial reloading in 1mM extracellular Ca2+, showed no statistically significant difference between WT (45.0±2.8 a.u.) and bax−/− cells (41.9±2.0 a.u.; P=0.38; Figures 3f and g), indicating that ER store refilling was not substantially altered by loss of Bax. Finally, the responses to physiological doses of ACh (100nM) were essentially unaffected as shown by sample traces (Figures 3h and i) and the response areas (Figure 3j).
Calcium-like peptides (CALPs) are short peptides designed by inversion of the hydrophobic pattern of EF hand Ca2+-binding sites,29 which generates molecules of a complementary surface contour, capable of interacting with the sequences of interest.30, 31 Cell permeable CALP-1 and CALP-3 can functionally mimic increased [Ca2+]i by modulating the activity of calmodulin, Ca2+ channels and pumps.32
Emptying the ER Ca2+ store with thapsigargin leads to opening of store-operated Ca2+ entry (SOCE) channels in the plasma membrane and influx of Ca2+ into the cytosol.33 As seen in Figures 4a–c, thapsigargin elicits an increase in [Ca2+]i which, in the absence of external Ca2+, is transient due to the extrusion of Ca2+ by the plasma membrane Ca2+ pumps. When Ca2+ is added to the external solution, [Ca2+]i increases again, due to SOCE (Figures 4a–c). In the absence of CALPs, the first and second application of 10mM Ca2+ induced similar [Ca2+]i elevations (Figure 4a). Addition of low concentrations (10μM) of CALP-1 (Figure 4b) or CALP-3 (Figure 4c) before the second application of 10mM Ca2+ substantially inhibited Ca2+ influx, as shown by markedly reduced amplitudes (P<0.001; Figure 4d).
Excessive cytosolic Ca2+ signals can trigger necrosis, associated with release of intracellular content followed by inflammation.34 Necrosis is especially dangerous for the pancreas, where released activated digestive enzymes cause a serious threat for the integrity of the tissue.35, 36 Therefore apoptosis, executed by cells in a controlled manner, is a more favourable pathway for killing cells. Here, CALPs were applied in an attempt to reduce elevations in [Ca2+]i and necrosis caused by BH3 mimetics. Preincubation of PACs either with 100μM CALP-1 or CALP-3 led to a decrease in the average amplitude of the Ca2+ signals occurring in response to BH3I-2′ (P<0.001 and P<0.05, respectively) compared to the control (average traces: Figure 5a; quantitative analysis: Figure 5b). This was due to a shift in the pattern of cytosolic Ca2+ signals elicited by 5μM BH3I-2′ (Figure 5c). The consequences of the CALP-mediated reductions in the cytosolic Ca2+ signal generation are reflected by the cell death pattern (Figures 5d and e). In the untreated control the majority of cells were alive (low levels of apoptosis and necrosis are due to enzymatic digestion of the tissue). Incubation with 5μM BH3I-2′ resulted in a 19.1±4.9% increase in apoptosis and a 31.7±8.1% increase in necrosis over the control levels (similar as in Figure 2f). In the presence of CALP-1, necrosis was significantly decreased (P<0.05), whereas apoptosis markedly increased (P<0.05) compared to BH3I-2′ alone. In contrast, CALP-3 did not affect apoptosis, but caused a reduction in necrotic cells (P<0.05) accompanied by an increase in the proportion of live cells (P<0.05).
It has been reported that gossypol is also capable of mobilising intracellular Ca2+.37, 38 Similarly to BH3I-2′ and HA14-1, in the absence of extracellular Ca2+, bax−/− cells did not respond to gossypol (Figure 6a, black trace). In WT cells in the presence of external Ca2+, 20μM gossypol alone caused an increase in [Ca2+]i reaching a sustained elevated plateau (Figure 6a). Preincubation either with 100μM CALP-1 or with CALP-3 led to a decrease in the magnitude of the Ca2+ responses to gossypol (Figures 6a and b; P<0.001); CALP-1 markedly decreased the proportion of cells that responded at all (Figure 6c). The effects of CALP-1 and CALP-3 on gossypol-induced cell death (Figures 6d and e) were very similar to those for BH3I-2′ (Figure 5d). In the presence of CALP-1, necrosis was markedly decreased (P<0.05) and the proportion of apoptotic cells was increased (P<0.05). CALP-3 reduced gossypol-induced necrosis (P<0.05) and increased the fraction of live cells (P<0.05).
The ability of CALPs to reduce excessive pathological Ca2+ signal generation is potentially very useful but given the crucial role of Ca2+ in the regulation of a wide variety of intracellular processes, it was important to test whether CALPs also affect physiological Ca2+ signalling. Nanomolar doses of ACh trigger enzyme secretion in PACs, an event controlled by Ca2+ signals.24 Here, 50nM ACh induced repetitive [Ca2+]i oscillations (Figure 7a). Preincubation with either 100μM CALP-1 (Figure 7b) or CALP-3 (Figure 7c) did not affect the ACh-elicited signals. The average areas of the responses to ACh in the presence and absence of CALPs were not found significantly different (Figure 7c, inset). Another secretagogue of the exocrine pancreas,39 CCK (5pM), induced oscillatory Ca2+ responses in acinar cells (Figure 7d). The presence of either CALP-1 (Figure 7e) or CALP-3 (Figure 7f) did not block the CCK-elicited responses, but the overall pattern was slightly changed (Figure 7g).
As the primary mechanism by which CALPs exert their effects is the pre-activation of EF hand Ca2+-binding sites on a wide variety of intracellular targets29 and inhibition of Ca2+ entry (Figures 4a–d), it is unlikely that CALP-mediated reduction in excessive Ca2+ signals and necrosis is limited only to the effects induced by BH3 mimetics. Menadione was previously shown to induce Ca2+-dependent cell death in PACs.40 Here, 5μM menadione was combined with a high physiological concentration of ACh (100nM) in order to induce Ca2+-dependent cell death of similar proportions of apoptosis and necrosis (25.1±5.0% and 20.7±1.7%, respectively; Figure 7h; sample images in Figure 7i) to those caused by BH3I-2′ (Figure 5d) or gossypol (Figure 6d). In this protocol 100μM CALP-1 decreased cell necrosis to control levels (P<0.05) while increasing slightly the proportions of both live and apoptotic cells; whereas 100μM CALP-3 substantially reduced necrosis (P<0.05), leading to an increase in the number of live cells (P<0.05). The apoptotic fraction was essentially unaffected by CALP-3.
It is now commonly accepted that Bcl-2 proteins are distributed in different cell compartments, not only at the outer mitochondrial membrane, but also in the cytosol, at the nuclear envelope and the ER.41, 42, 43 An increasing number of reports indicates that Bcl-2 itself may either directly or indirectly modulate intracellular Ca2+ fluxes such as: (1) Ca2+ release from the ER by binding to IP3Rs or RyRs;44, 45, 46 (2) Ca2+ reuptake into the ER by SERCA;47 (3) cellular Ca2+ extrusion by PMCA (plasma membrane Ca2+ ATPase);48 (4) and mitochondrial Ca2+ load.49
We have previously demonstrated that the BH3 mimetics BH3I-2′ and HA14-1 induce Ca2+ release from the intracellular stores in mouse PACs and in the rat pancreatic cancer cell line AR42J.16 This Ca2+ release was not completely blocked by inhibition of IP3Rs and RyRs indicating involvement of other Ca2+ channels. We have also shown that BH3I-2′ and HA14-1 displace Bax from Bcl-2 and Bcl-xL.16 Here we provide new insights into the mechanism of this phenomenon by demonstrating that loss of Bax, but not Bak or Bcl-2, substantially inhibited Ca2+ responses to BH3I-2′ (Figure 1a), HA14-1 (Figure 1b) and gossypol (Figure 6a) in the absence of extracellular Ca2+. HA14-1 and gossypol were suggested to have off-target effects,50, 51 and recently a novel Bcl-2 inhibitor, ABT-199, was found not to affect intracellular Ca2+ signalling.52 In our experiments not only the responses to HA14-1 and BH3I-2′ were markedly inhibited in bax−/− PACs (Figures 1a and b) but also BH3I-2′-elicited apoptosis was completely abolished (Figure 2f), indicating that these effects were dependent on Bax. Low levels of necrosis in bax−/− cells may indeed suggest a Bax-independent killing component in the mechanism of BH3I-2′ action. Importantly, BH3I-2′-induced cell death in PACs appears to be mediated by Ca2+ as it was blocked by chelation of intracellular Ca2+ with BAPTA (Figure 2f).
Our results appear to link Bax with the process of passive Ca2+ leak from the ER. The leak, unmasked by thapsigargin, developed more slowly in bax−/− cells compared to WT cells (Figures 3c and e). Currently there is an on-going dispute about the nature of the channels mediating this process. As Bax can localise to the ER membranes53 and given that its structure resembles that of pore-forming bacterial toxins,54, 55 Bax itself might be able to form a channel permeable to ions and thus contribute to the passive Ca2+ leak. Two out of seven α-helices of Bax were suggested to function as pore-forming domains, but possibly more than one monomer of Bax would need to form a functional ion-permeable pore.56, 57 Alternatively, as opposed to acting as a channel itself, Bax could directly or indirectly regulate the ER Ca2+ leak mediated by other channels. Consequently, it could be speculated that application of a BH3 mimetic increases the unbound fraction of Bax, which activates Ca2+ channels in the ER, thus potentiating the leak (Figure 8). The leak may be further amplified by IP3Rs and RyRs.
The reduced cytosolic Ca2+ release in response to thapsigargin treatment in bax−/− cells could, in principle, be explained by a diminished resting ER Ca2+ content. However, as ACh-induced oscillations were essentially unaffected in bax−/− cells (Figures 3h–j), this may indicate that the [Ca2+]ER has not been substantially affected by loss of Bax. Previous experiments demonstrated that ACh-evoked short-lasting Ca2+ spikes in PACs are very sensitive to even minor reductions in [Ca2+]ER and cease after a relatively modest decrease in [Ca2+]ER.58 This could shed new light on a seeming discrepancy found in the previous studies, whereby both knockdown59, 60 and overexpression61, 62 of Bax led to a reduction in Ca2+ responses induced by various agonists or inhibition of SERCA. It is likely that upon loss of Bax, some of the leak channels are inactive, and those that remain active may be sensitive to changes in [Ca2+]ER and, for example, close early in the release period thereby limiting Ca2+ release from the ER. In contrast, overexpression of Bax may lead to an increased basal leak, which results in a decrease in resting [Ca2+]ER and thus dampens Ca2+ responses. Finally, under normal conditions, Bax is sequestrated by anti-apoptotic Bcl-2 family proteins. But any shifts in the balance between anti- and pro-apoptotic Bcl-2 members may promote mechanisms that either favour pro-survival Ca2+ transients or larger pro-apoptotic Ca2+ signals.63
Further, our results show that the BH3 mimetics, BH3I-2′ and gossypol not only induce apoptosis in PACs but also cause substantial levels of necrosis (Figures 5d and and6d).6d). Cell death in PACs was a downstream effect of large cytosolic Ca2+ signals triggered by application of BH3 mimetics, as (1) Ca2+ chelation by BAPTA completely abolished both apoptosis and necrosis induced by BH3I-2′ and (2) reduction of Ca2+ signals elicited by CALP-1 or CALP-3 (Figures 5a and and6a)6a) led to a significant decrease in BH3I-2′- as well as gossypol-induced necrosis (Figures 5d and and6d).6d). CALP-1 was shown to be particularly promising, as it effectively shifted the cell death mode from necrosis to apoptosis. In contrast, CALP-3 substantially reduced BH3 mimetic-induced necrosis while increasing the fraction of live cells. Both CALPs were capable of inhibiting Ca2+ entry (Figures 4a–d), even though they differ in structure. CALP-1 has been designed to interact with EF hand Ca2+-binding sites of troponin C, whereas CALP-3 is complementary to the EF hand motif of calmodulin.32 It is therefore likely that the two CALPs might preferentially interact with different intracellular targets, for example, Ca2+ channels regulated by Ca2+ versus calmodulin, abundant in PACs.64 This could explain different effects on BH3 mimetic-induced cell death. Previously we demonstrated that CALP-3 efficiently inhibited Ca2+ responses induced by ethanol in PACs and we attributed this effect to activation of calmodulin.65 The exact assessment of binding affinities of CALPs to intracellular targets exceeds the scope of this work. It is clear, however, that the effects of CALPs on cell death are not limited to BH3 mimetics, as necrosis triggered by ACh and menadione was also inhibited in the presence of CALPs (Figure 7h).
Considering the vast spectrum of targets affected by CALPs, it was important to test whether application of these compounds would affect not only pathological Ca2+ elevations but also physiological Ca2+ signals. In PACs, nanomolar doses of ACh and picomolar concentrations of CCK are known to trigger Ca2+ oscillations, which regulate pancreatic enzyme secretion.24 In our experiments neither CALP-1 nor CALP-3 markedly affected responses to ACh (Figures 7a–c), whereas in the presence of CALP-3, CCK-elicited Ca2+ oscillations were slightly reduced but not completely inhibited (Figures 7d–g). The previously demonstrated inhibition of Ca2+ influx into PACs by the CRAC channel inhibitor GSK-7975A also affected only pathological Ca2+ elevations but not the oscillations induced by physiological concentrations of ACh or CCK.66
Although it can be triggered by sustained elevations of [Ca2+]i, necrosis generally lacks intracellular regulatory mechanisms. This severely limits possible therapeutic approaches in diseases where necrosis plays a major role, such as acute pancreatitis. Inhibition of SOCE has already been demonstrated to decrease cell death in vitro66 and in vivo.67 This study provides another proof-of-principle demonstration that even non-specific attenuation of intracellular Ca2+ fluxes can dampen pathophysiological Ca2+ responses and thus result in necrosis inhibition (CALP-3) or a significant shift in cell death towards apoptosis (CALP-1).
Our results indicate that application of CALPs, especially CALP-1, could improve the outcome of BH3 mimetic-based therapies. Although the pharmacokinetic properties of CALPs have not yet been studied in detail, it is likely that CALPs share characteristics of other short peptides, such as limited cell permeability and metabolic instability.68 However, development of synthetic non-peptide compounds activating EF hand Ca2+-binding motifs could potentially overcome these limitations, providing a useful pharmacological switch of cell death mode, particularly in cancer therapies.
The main reagents for cell isolation and imaging include: Fluo-4 AM, Fura-2 AM, Fluo-5N AM and BAPTA AM (ThermoFisher Scientific, Paisley, UK); collagenase (Worthington Biochemical Corporation, Lakewood, NJ, USA); inorganic salts (Sigma-Aldrich, Gillingham, UK). Other reagents: HA14-1 (Alexis Biochemicals, San Diego, CA, USA); BH3I-2′, gossypol (Santa Cruz Biotechnology, Dallas, TX, USA); caffeine and thapsigargin (Calbiochem, Nottingham, UK); CALP-1, CALP-3, ruthenium red and CDN1163 (Tocris Bioscience, Bristol, UK). NaHEPES buffer was prepared as follows (mM): NaCl 140, KCl 4.7, HEPES 10, MgCl2 1, glucose 10; pH 7.2. KHEPES (intracellular solution) consisted of (mM): KCl 130, NaCl 18, MgCl2 1, HEPES 10, ATP 3, EGTA 0.1, CaCl2 0.05; pH 7.2.
All procedures involving animals were performed in accordance with the UK Home Office regulations. C57BL/6J mice (male, 6–8 weeks old, 23±3g weight) were supplied by Charles River Laboratories (Margate, UK); transgenic mice bcl-2−/− (B6;129S2-BCL-2tm1Sjk/J), bax−/− (B6.129X1-Baxtm1Sjk/J) were obtained from The Jackson Laboratories (Bar Harbor, ME, USA); bak−/− (B6.129-Bak1tm1Thsn/J) colony was a gift of Professor David Mark Pritchard (University of Liverpool); bax−/− strain extensively crossed into the CD1 background was also obtained from Professor Alun Davies (Cardiff University).69 Transgenic mice were bred in house either from null (bak−/−) or heterozygous (bcl-2−/−, bax−/−) parents; the genotype of each mouse was confirmed by PCR reaction with primers suggested by the supplier. All animals were housed in the institutional animal unit, maintained on a 12 h light cycle on a standard rodent chow diet with free access to water. The mice were killed according to Schedule 1 of Animals (Scientific Procedures) Act 1986, dissected and the pancreatic tissue was removed for further experimental procedures.
PAC isolation and most of the experimental work was carried out in NaHEPES buffer. Unless otherwise stated, NaHEPES was supplemented with 1mM Ca2+. Freshly isolated pancreas was washed twice in NaHEPES, injected with collagenase (200μ/ml, in NaHEPES) and subsequently incubated at 37°C for 15min in the collagenase solution to allow digestion of the tissue. After incubation, the pancreas was broken down by pipetting, suspended in NaHEPES, spun (1min, 0.2 × g), resuspended in NaHEPES and spun again. Finally, isolated PACs were suspended in NaHEPES and loaded with a Ca2+ sensitive dye as described below.
Isolated PACs were loaded at room temperature with one of the Ca2+ indicators: 5μM Fluo-4 AM for 30min or 10μM Fura-2 AM for 1h. After the incubation the cells were resuspended in fresh NaHEPES and used for experiments at room temperature in a flow chamber perfused with NaHEPES-based extracellular solution. Experiments with Fluo-4 AM were performed using the Leica confocal microscope TCS SPE (Leica Microsystems, Milton Keynes, UK): × 63 oil objective, excitation 488nm, emission 500–600nm. Static images were taken at 512 × 512 pixel resolution and series of images were recorded at 256 × 256 pixel resolution, two consecutive frames were averaged. Fluorescence signals were plotted as F/F0, where F0 was an averaged signal from the first ten baseline images. Experiments with Fura-2 AM were performed using the Nikon Diaphot 200 imaging system (Nikon, Kingston, UK): excitation at 365 and 385nm, emission at 510nm. The signals were plotted as 365/385nm ratio or the ratio normalized to baseline values (R/R0).
PACs were loaded with 5μM Fluo-5N AM in NaHEPES for 45min at 37°C. After the incubation, the cells were resuspended in fresh NaHEPES and used for experiments at room temperature in a flow chamber perfused with KHEPES-based intracellular solution. The cells were permeabilised with two-photon laser beam (720–750nm),70 which was applied at a small area of the plasma membrane of a PAC. The experiments were performed using the Leica two-photon confocal microscope TCS SP5 with the same settings as for Fluo-4 AM (see above).
Cell death assay was performed using Annexin V-FITC Apoptosis Detection Kit (Sigma-Aldrich) according to a modified manufacturer′s protocol. PACs were isolated as described above and divided equally into four experimental groups. Two samples were pretreated with 100μM CALP-1 or 100μM CALP-3 for 15min at room temperature; the remaining two were incubated without pretreatment. Then cell death was induced for 30min in both samples containing CALPs and in one untreated sample. Depending on the experiment, either one of BH3 mimetics was used (5μM BH3I-2′ or 5μM gossypol) or 5μM menadione together with 100nM ACh. Analogical experiments were performed with 15min pretreatment with BAPTA instead of CALPs. The control samples were left untreated. Fifteen minutes before the end of the incubation, annexin V-FITC and propidium iodide were added to all samples. The cells were visualised with the Leica confocal microscope TCS SPE. Annexin V-FITC specifically stained apoptotic cells (excitation: 488nm, emission: 510–570nm), whereas propidium iodide was used for detection of necrotic cells (excitation: 535nm, emission: 585–705nm). Multiple pictures (20–35) per treatment group were taken; live, apoptotic and necrotic cells were counted in each treatment group.
For quantitative analysis of Ca2+ responses, areas under individual traces were calculated according to the formula: , where F is the recorded fluorescence (or ratio for Fura-2), F0 is the baseline fluorescence (or ratio) and Δt – time interval. Obtained values were then averaged and presented as bar charts with S.E.M. The Student′s t-test was applied for statistical comparison. The significance threshold was set at 0.05 and the range was indicated by asterisks (*P<0.05, **P<0.01, ***P<0.001). Where applicable, N indicates the number of individual experiments, whereas n – individual cells.
For cell death assays, three independent experiments were performed for each treatment group; average values and S.E.M. were calculated and the results presented as bar charts. Statistical analysis was performed using the non-parametric Mann–Whitney U-test with the significance threshold set at 0.05.
This work was supported by a Medical Research Council Programme Grant MR/J002771/1. OHP is a Medical Research Council Professor (G19/22/2) and PEF was a Wellcome Trust-funded PhD student. We would like to thank Professor Alun Davies and Dr. Blanca Paramo (Cardiff University) for sharing bax−/− mice as well as Ms Veronica Walker (Chief Technician, Joint Biological Services, Cardiff University) for advice and support related to transgenic mouse colonies.
Edited by J Chipuk
The authors declare no conflict of interest.